Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Learn more about platelets, small types of blood cells that prevent excessive bleeding and serve other important purposes.

Six months in, and this mid-ranger still outpaces newer phones — and it might just be 2025’s smartest buy.

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system's ability to ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

In addition to the receptor used to locate tumor cells, this treatment adds an element that further enhances the immune ...

You can see it in our review score — the CMF Phone 2 Pro ranks well above the average for its price class, with excellent ...

Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

(Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and ...

WALTHAM, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...